News

Exclusive: Alzheimer’s jab halves rate of decline, study finds - The Telegraph

CO

Laura has led award-winning coverage on the NHS, medical science breakthroughs, and public health policy across the UK for The Telegraph. Her reporting can be found on X: @lauradonnlee A jab given just twice a year has halved the rate of cognitive decline in Alzheimer’s patients , with scientists describing the results as “thrilling”. In a major trial, patients given low-dose diranersen injections showed 54 per cent less decline on a test of memory and thinking over almost two years. The findings suggest that the treatment could prove the most powerful to slow Alzheimer’s yet. It is also the first to show a reduction in tau, a protein that forms damaging tangles linked to brain cell death.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.